Sustained GH & Growth Factor Signaling Stack – Bundle

The Advanced GH Optimization Research Stack (CJC-DAC, Ipamorelin, IGF-1 LR3) is a formulation selected by research teams investigating sustained growth hormone signaling alongside downstream growth-factor–mediated pathways within controlled experimental models. This stack is designed to support long-range GH-axis engagement combined with IGF-linked anabolic signaling, representing the highest tier of endogenous GH optimization research.

By integrating prolonged GH release with downstream IGF activity, this formulation enables comprehensive investigation into advanced endocrine signaling environments.

Includes

• 5 vials of CJC-1295 with DAC (5 mg each)
  
• 3 vials of Ipamorelin (10 mg each)
  
• 3 vials of IGF-1 LR3 (1 mg each)
  

This advanced research stack is designed for comprehensive study of the growth hormone (GH) system, combining sustained hormone elevation with investigation into its downstream cellular effects.

The stack integrates three compounds, each studied for a distinct role:

• CJC-1295 (with DAC) is researched for its prolonged activity, providing a steady, sustained stimulus for GH release over an extended period.
• Ipamorelin complements this by adding selective, pulsatile stimulation, helping to maintain the body’s natural rhythmic release pattern alongside the sustained signal.
• IGF-1 LR3 is included to allow research into the downstream pathways activated by GH. It is studied for its role in mediating cellular-level responses related to growth and repair.

This combination creates a multi-stage research model. It allows for the examination of both a prolonged GH exposure and its subsequent translation into growth factor signaling. This provides a framework for advanced study of how extended endocrine signaling influences tissue-level processes, representing a comprehensive approach within endogenous GH research.

Mechanism and Research Focus

This stack enables the study of the GH axis from stimulation to cellular effect:

Downstream Action: IGF-1 LR3 is examined for its extended activity, allowing research into the tissue-level growth and anabolic signaling that follows GH release.

Sustained Stimulation: CJC-1295 with DAC is investigated for its ability to provide a long-acting stimulus to the pituitary gland, leading to prolonged GH availability.

Rhythmic Signaling: Ipamorelin is studied for its role in supporting the natural pulsatile rhythm of GH release, even within a sustained model.

Key Research Observations

Research has shown this stack may help support the following in non-clinical models:

• Prolonged GH Exposure: Observing markers related to extended growth hormone signaling.
• Maintained Release Rhythm: Assessing the preservation of natural pulsatile hormone patterns during sustained stimulation.
• Cellular Growth Signaling: Investigating the downstream activity of insulin-like growth factors (IGF-1) at the cellular level.
• Integrated System Analysis: Profiling the interaction between prolonged endocrine signaling and subsequent tissue-level responses.
  

Form and Handling

Research-grade peptides supplied in lyophilized powder format. Vials are provided individually and aligned to stack components. Store frozen at approximately −20 °C and protect from light to preserve compound stability throughout the research period.

Research Use Only

For laboratory research use only. Not for human or animal consumption, medical use, or therapeutic application.